What have pharmacies paid for Hydroxyurea since 2013?
What pharmacies pay, not what you pay. Hydroxyurea has 1 product in the CMS NADAC survey, 1 product with year-end prices in more than one year. NADAC is what pharmacies pay to acquire a drug, not what a patient is charged. Hydroxyurea 500 MG Capsule: $0.351 per unit at the 2013 survey and $0.184 at 2026 (−47%).
Not medical or financial advice. This page reports what pharmacies pay to acquire a drug, from the CMS NADAC survey. It is not what you will be charged, and it says nothing about which medicine is right for you. Ask your pharmacist or prescriber.
Hydroxyurea1 product in NADAC
1product with a price history
Hydroxyurea has 1 product in the CMS NADAC survey, 1 product with year-end prices in more than one year. NADAC is what pharmacies pay to acquire a drug, not what a patient is charged.
Between each product's first and latest year-end survey, 1 product costs pharmacies less and none costs more, by more than 5 percent, per unit as CMS states it.
This is a per-unit acquisition cost, not a retail price, a copay or an insurer's price, and it says nothing about why a price moved.
Hydroxyurea 500 MG Capsule
Generic
$0.351 per unit at the 2013 year-end survey (3 NDCs) and $0.184 at the 2026 survey (7 NDCs): −47%.
year-end median across the NDCs pricedlowest to highest NDC
Year-end survey
Median per unit
Lowest to highest
NDCs priced
2013 (2013-12-25)
$0.351
3
2014 (2014-12-31)
$0.353
4
2015 (2015-12-30)
$0.372
4
2016 (2016-12-28)
$0.323
4
2017 (2017-12-27)
$0.301
4
2018 (2018-12-26)
$0.292
4
2019 (2019-12-25)
$0.294
5
2020 (2020-12-30)
$0.298
5
2021 (2021-12-29)
$0.254
5
2022 (2022-12-28)
$0.272
6
2023 (2023-12-27)
$0.223
6
2024 (2024-12-25)
$0.259
7
2025 (2025-12-31)
$0.203
7
2026 (2026-11-11)
$0.184
7
CMS National Average Drug Acquisition Cost, year-end surveys 2013 to 2026. A pharmacy acquisition cost, not a retail price. About NADAC.
How many companies make Hydroxyurea?
The FDA Orange Book lists 4 generic makers as marketed in its largest dosage form for Hydroxyurea, and the first generic approval is dated 18 August 1995. The acquisition costs above are what pharmacies pay across the NDCs priced; the Orange Book count is a separate record and this page does not say that more makers lowered a price. See each maker and the patents still listed on OmniRx.